Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial.

Eva-Maria Klein, Diana Tichy, Hans J Salwender, Elias K Mai, Jan Duerig, Katja C Weisel, Axel Benner, Uta Bertsch, Mabast Akhavanpoor, Britta Besemer, Markus Munder, Hans-Walter Lindemann, Dirk Hose, Anja Seckinger, Steffen Luntz, Anna Jauch, Ahmet Elmaagacli, Stephan Fuhrmann, Peter Brossart, Martin GoernerHelga Bernhard, Marc S Raab, Igor W Blau, Mathias Haenel, Christof Scheid, Hartmut Goldschmidt, On Behalf Of The German-Speaking Myeloma Multicenter Group Gmmg

Research output: Contribution to journalOriginal Article (Journal)peer-review

4 Citations (Web of Science)
Original languageEnglish
JournalCancers
Volume13
Issue number19
DOIs
Publication statusPublished - 2021

Keywords

  • STEM-CELL TRANSPLANTATION
  • LONG-TERM SURVIVAL
  • PROGRESSION
  • BORTEZOMIB
  • CRITERIA
  • ASSAY
  • IMMUNOGLOBULINS
  • PREDICTION
  • REDUCTION
  • DIAGNOSIS

Cite this